Standing More Can Benefit Cardiometabolic Health

This article originally appeared here.
Share this content:
Standing More Can Benefit Cardiometabolic Health
Standing More Can Benefit Cardiometabolic Health

(HealthDay News) -- Sitting appears to be linked to increased blood glucose and cholesterol levels, but standing more helps improve all these measures, according to research published online July 31 in the European Heart Journal.

Genevieve Healy, Ph.D., a senior research fellow at the University of Queensland in Herston, Australia, and colleagues gave activity monitors to 782 men and women, aged 36 to 80, who took part in the Australian Diabetes, Obesity, and Lifestyle Study. The monitors kept track of how long each participant spent sitting/lying down, standing, walking, and running. In addition, participants provided blood samples, measurements of their blood pressure, waist circumference, and body mass index (BMI). The monitors were worn 24 hours a day for seven days.

The researchers found that an extra two hours per day spent standing rather than sitting was associated with approximately 2 percent lower blood glucose levels and 11 percent lower average triglycerides. More standing time was also associated with an increase in high-density lipoprotein (HDL) cholesterol and a drop in low-density lipoprotein cholesterol. Replacing two hours a day of sitting time with walking or running was associated with an approximately 11 percent lower average BMI and an approximately 3-inch decrease in waist circumference. The researchers also found that average blood glucose levels dropped by about 11 percent and average triglycerides by 14 percent for every two hours spent walking rather than sitting, while HDL cholesterol levels increased 0.10 mmol/L.

"Findings suggested that sitting-reduction strategies targeting increased standing, stepping, or both, may benefit cardiometabolic health," the authors write. "Standing is a simple alternative to sitting, and requires further examination in prospective and intervention studies."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »